Fig. 1 · Structure
Documents & Downloads
CBN209350
KDM4 Inhibitor
CBN209350 is a selective inhibitor of the lysine demethylase KDM4, exhibiting an IC50 of 4 μM. This compound demonstrates significant antiproliferative effects on prostate cancer cells, making it a valuable tool for investigating prostate cancer biology. CBN209350 is suitable for research applications aimed at understanding the role of KDM4 in cancer progression and therapeutic development.
In Stock
Free Aliquoting for Your Order
Tell us your preferred amount per vial. We’ll confirm the options.
Specifications
| Manufacturer | Adooq Bioscience |
|---|---|
| Actions | Inhibitor |
| CAS Number | 726201-10-1 |
| Applications | KDM4 Inhibitor |
| Formula | C13H12N4O3 |
| Molecular Weight | 272.26 |
| SMILES | O=C(OC)CC1=NN(C(=O)C1)C2=NC=3C=CC=CC3N2 |
Storage & Solubility
In Vitro Solubility
Reported Solubility
No reported solubility data are available for this product.
Preparing Stock Solutions
| Concentration | |
|---|---|
Values use four significant digits. Prepare to the final solution volume; this is not the volume of solvent to add.
Stock preparation is unavailable for this product molecular weight.
Calculated stock concentrations do not establish solvent solubility. Refer to the reported solubility data for experimental guidance.
Storage
Store powder at -20°C, keep desiccated.
In powder form, the chemical is stable for 36 months.
In solution, store at -20°C and use within 1 month to prevent loss of potency. Aliquot to avoid multiple freeze/thaw cycles.